The global coronavirus immunoassay market continues to witness steady growth, reaching USD 3.7 billion in 2021 and is projected to exceed USD 6.9 billion by 2032, expanding at a CAGR of 5.5% during ...
Thanks to predictive and preventive medicine. The global immunoassay market is projected to grow by $8.64b until 2028 at a compound annual growth rate of 4.42%, said Technavio. The sector’s ...
The US Food and Drug Administration (FDA) has granted 510(k) clearance to Beckman Coulter Diagnostics' new DxC 500i Clinical ...
Ahomebrewbead-based immunoassay begins with the capture and labeling of an analyte using an enzyme conjugate (streptavidin ß-galactosidase, SBG). The analyte is captured with beads, and a ...